Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma

por Thomas, E, Shaw, R J, Risk, J M
Publicado 2005

Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.

por Swift, A., Risk, J. M., Kingsnorth, A. N., Wright, T. A., Myskow, M., Field, J. K.
Publicado 1995

The epigenetic landscape of oral squamous cell carcinoma

por Jithesh, P V, Risk, J M, Schache, A G, Dhanda, J, Lane, B, Liloglou, T, Shaw, R J
Publicado 2013

Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

por Shaw, R J, Liloglou, T, Rogers, S N, Brown, J S, Vaughan, E D, Lowe, D, Field, J K, Risk, J M
Publicado 2006

SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma

por Dhanda, J, Triantafyllou, A, Liloglou, T, Kalirai, H, Lloyd, B, Hanlon, R, Shaw, R J, Sibson, D R, Risk, J M
Publicado 2014

Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma

por Schache, A G, Hall, G, Woolgar, J A, Nikolaidis, G, Triantafyllou, A, Lowe, D, Risk, J M, Shaw, R J, Liloglou, T
Publicado 2010

Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.

por Field, J. K., Kiaris, H., Risk, J. M., Tsiriyotis, C., Adamson, R., Zoumpourlis, V., Rowley, H., Taylor, K., Whittaker, J., Howard, P.
Publicado 1995

Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.

por Field, J. K., Neville, E. M., Stewart, M. P., Swift, A., Liloglou, T., Risk, J. M., Ross, H., Gosney, J. R., Donnelly, R. J.
Publicado 1996

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma

por Schache, A G, Liloglou, T, Risk, J M, Jones, T M, Ma, X-J, Wang, H, Bui, S, Luo, Y, Sloan, P, Shaw, R J, Robinson, M
Publicado 2013

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer

por Shaw, R J, Omar, M M, Rokadiya, S, Kogera, F A, Lowe, D, Hall, G L, Woolgar, J A, Homer, J, Liloglou, T, Field, J K, Risk, J M
Publicado 2009

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer

por Yao, S, Ireland, S J, Bee, A, Beesley, C, Forootan, S S, Dodson, A, Dickinson, T, Gerard, P, Lian, L-Y, Risk, J M, Smith, P, Malki, M I, Ke, Y, Cooper, C S, Gosden, C, Foster, C S
Publicado 2012